Related Experiment Video
Updated: Dec 13, 2025
05:30
Author Spotlight: Advancing the Analysis of Plasma Extracellular Vesicle Proteome for Cardiovascular Biomarker Studies
Published on: January 31, 2025
916
Extracellular vesicles in atrial fibrillation and stroke
Åsa Thulin1, Johan Lindbäck2, Christopher B Granger3
1Department of Medical Sciences, Clinical Chemistry, Uppsala University, Uppsala, Sweden.
Thrombosis Research
|July 28, 2020
Summary
Extracellular vesicles (EVs) are elevated in atrial fibrillation (AF) patients, but do not appear to be a primary cause of stroke in this population. Further research is needed to understand their role in AF-related cardiovascular events.
Area of Science:
- Cardiovascular Research
- Biomarker Discovery
- Hematology
Background:
- Atrial fibrillation (AF) significantly increases the risk of thromboembolic stroke.
- Extracellular vesicles (EVs) are implicated in disease processes and may serve as stroke biomarkers.
Purpose of the Study:
- To investigate the role of extracellular vesicles (EVs) in atrial fibrillation (AF) patients.
- To determine if EVs are associated with stroke risk in AF.
Main Methods:
- Measured EVs from platelets, leukocytes, erythrocytes, and endothelial cells in AF patients and a healthy cohort.
- Utilized flow cytometry and proximity ligation assay for EV quantification.
- Correlated EV levels with clinical markers like NT-ProBNP and D-dimer.
Main Results:
- AF patients exhibited higher concentrations of most EV types compared to the general population.
- EV concentrations did not differ significantly between AF patients with and without stroke.
- Leukocyte EVs correlated with IL-6, suggesting involvement in inflammatory processes.
Conclusions:
- Elevated EVs in AF patients likely reflect disease burden rather than direct stroke mediation.
- EVs may not be a key mediator of stroke occurrence in atrial fibrillation.
- Further investigation into the specific roles of different EV subtypes in AF pathophysiology is warranted.
Related Concept Videos
01:30Venous Thrombosis I: Introduction
168
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
168
01:36Overview of Exosomes
3.3K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
3.3K
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.4K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.4K
01:16Clot Retraction and Fibrinolysis
8.0K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
8.0K